Kerry

Developing a robust roller compaction process can be challenging, due to the diversity in process parameters and material properties of...

15th February 2022: Kerry, the world’s leading taste and nutrition company, has announced that it has made two significant biotechnology...

Today is the last day of the CPhI worldwide in Milan 2021. We want to show you the general look...

CPhI worldwide opens its real doors again after one year of digital trade show! This year in Milan at the...

At Kerry, we recognize the need to continually evolve our film coatings to ensure we meet our customer needs who...

Update from October 7th: News on EU commission's decision: On what have the member states voted on 7 October and...

In the next weeks, several very interesting webinars for the excipient community are scheduled. Here, we made a short overview...

Tablets constitute about 80–90% of dosage forms commonly prescribed by medical practitioners for therapeutic management of disease conditions. It is...

SYN-004 (ribaxamase) delayed release drug product is a multi-particulate, hard capsule for oral delivery of a recombinant β-lactamase enzyme designed...

Tablet Coating Webinar by Kerry - December 17, 2020 Big pharma manufacturers are moving away from traditional in-house coating to...